Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell Death and Differentiation

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cdd.4402122PMID 17380155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.

  2006cited by this paper
• The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs)

  2006influential reference
• The apoptosome: physiological, developmental, and pathological modes of regulation.

  2006influential reference
• Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non‐microdeletion patients

  2006influential reference
• Pro-apoptotic Proteins Released from the Mitochondria Regulate the Protein Composition and Caspase-processing Activity of the Native Apaf-1/Caspase-9 Apoptosome Complex*

  2004influential reference
• Genomic organization and evolution of the NF1 microdeletion region.

  2004influential reference
• Elevated risk for MPNST in NF1 microdeletion patients.

  2003cited by this paper
• Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse

  2003influential reference
• Death and anti-death: tumour resistance to apoptosis

  2002cited by this paper
• Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies1

  2002cited by this paper
• The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1*

  2002cited by this paper
• Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization

  2002influential reference
• Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome

  2002influential reference
• Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.

  2002influential reference
• Building protein-protein networks by two-hybrid mating strategy.

  2002cited by this paper
• Identification of Ipaf, a Human Caspase-1-activating Protein Related to Apaf-1*

  2001cited by this paper
• Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes.

  2000influential reference
• NF1 microdeletion breakpoints are clustered at flanking repetitive sequences.

  2000influential reference
• Apaf-1 Oligomerizes into Biologically Active ∼700-kDa and Inactive ∼1.4-MDa Apoptosome Complexes*

  2000cited by this paper
• NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.

  2000influential reference
• TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency.

  1999cited by this paper
• Death by design: mechanism and control of apoptosis.

  1999influential reference
• Caspase structure, proteolytic substrates, and function during apoptotic cell death

  1999influential reference
• Role of cytochrome c and dATP/ATP hydrolysis in Apaf‐1‐mediated caspase‐9 activation and apoptosis

  1999influential reference
• Differential requirement for caspase 9 in apoptotic pathways in vivo.

  1998influential reference
• Mitochondria and apoptosis.

  1998influential reference
• Two CD95 (APO‐1/Fas) signaling pathways

  1998influential reference
• Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1.

  1998influential reference
• Apaf1 is required for mitochondrial pathways of apoptosis and brain development.

  1998influential reference
• Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay

  1998influential reference
• Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development.

  1998influential reference
• Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata.

  1997influential reference
• Deletion of the entire NF1 gene causing distinct manifestations in a family.

  1997influential reference
• Do NF1 gene deletions result in a characteristic phenotype?

  1997influential reference
• Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

  1997cited by this paper
• Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype‐phenotype correlations in neurofibromatosis type 1?

  1997cited by this paper
• Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

  1996influential reference
• Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations.

  1995influential reference
• Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.

  1994influential reference

• Pathogen-induced apoptosis in echinoderms: A review.

  2024cites this paper
• Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review

  2024cites this paper
• Molecular etiology of defective nuclear and mitochondrial ribosome biogenesis: Clinical phenotypes and therapy.

  2022cites this paper
• Contribution of Apaf-1 to the pathogenesis of cancer and neurodegenerative diseases.

  2021cites this paper
• The Role of Co-Deleted Genes in Neurofibromatosis Type 1 Microdeletions: An Evolutive Approach

  2019cites this paper
• Distinct pathways associated with chromosomal aberration frequency in a cohort exposed to genotoxic compounds compared to general population.

  2019cites this paper
• The anticancer peptide RT53 induces immunogenic cell death

  2018cites this paper
• Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes

  2018cites this paper
• Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer

  2017cites this paper
• Apaf-1: Regulation and function in cell death.

  2017cites this paper
• Emerging genotype–phenotype relationships in patients with large NF1 deletions

  2017cites this paper
• ANALYSIS OF THE IN VIVO FUNCTION OF HASPIN KINASE USING ZEBRAFISH AS A MODEL SYSTEM: KNOCKDOWN AND KNOCKOUT APPROACHES

  2016cites this paper
• Expression of ribosomopathy genes during Xenopus tropicalis embryogenesis

  2016cites this paper
• A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death.

  2016cites this paper
• Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth

  2015influential citation
• DNA damage-induced nuclear translocation of Apaf-1 is mediated by nucleoporin Nup107

  2015cites this paper
• Caspase-9 as a therapeutic target for treating cancer

  2015influential citation
• ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome

  2014cites this paper
• Human diseases of the SSU processome.

  2014cites this paper
• Mammalian HCA66 protein is required for both ribosome synthesis and centriole duplication

  2012influential citation
• Surgical Treatment of a Giant Neurofibroma

  2011cites this paper
• Apaf1 plays a pro-survival role by regulating centrosome morphology and function

  2011cites this paper
• Identification of Genes Potentially Involved in the Increased Risk of Malignancy in NF1-Microdeleted Patients

  2011cites this paper
• Apaf 1 plays a pro-survival role by regulating centrosome morphology and function

  2011cites this paper
• When ribosomes go bad: diseases of ribosome biogenesis.

  2010cites this paper
• Regulation of the Apaf-1–caspase-9 apoptosome

  2010cites this paper
• Molecules That Bind a Central Protein Component of the Apoptosome, Apaf-1, and Modulate Its Activity

  2010cites this paper
• Putative Role of HCA66, A New Apaf-1 Interacting Protein, in the Physiopathology of NF1 Microdeletion Syndrome Patients

  2010cites this paper
• Apoptosome: An up-and-coming therapeutical tool

  2010cites this paper
• Regulation of Apoptosis Following Mitochondrial Cytochrome c Release

  2010cites this paper
• The Apoptosome: The Executioner of Mitochondria‐mediated Apoptosis

  2009cites this paper
• Discovery and development of Apaf-1 inhibitors: advancing towards unwanted cell death treatments

  2009cites this paper
• Stability of the small γ-tubulin complex requires HCA66, a protein of the centrosome and the nucleolus

  2009cites this paper
• Regulation of apoptosis at the point of cytochrome c in disease models

  2009cites this paper
• Mitochondria, Bcl-2 family proteins and apoptosomes: of worms, flies and men.

  2009cites this paper
• Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation

  2009cites this paper
• Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector

  2008cites this paper
• Regulation of apoptosis in postmitotic cells

  2008cites this paper
• Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance

  2008influential citation
• Postmitochondrial regulation of apoptosis in neurons and cancer cells

  2007cites this paper